Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. (2018)

First Author: Connick P
Attributed to:  EPICure@19 - the extremely preterm young adult funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-021944

PubMed Identifier: 30166303

Publication URI: http://europepmc.org/abstract/MED/30166303

Type: Journal Article/Review

Volume: 8

Parent Publication: BMJ open

Issue: 8

ISSN: 2044-6055